SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+10.93%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$574M
AUM Growth
+$574M
(-8.1%)
Cap. Flow
-$49.9M
Cap. Flow
% of AUM
-8.69%
Top 10 Holdings %
Top 10 Hldgs %
40.42%
Holding
159
New
26
Increased
30
Reduced
26
Closed
52
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$16.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.3M |
| 3 |
NMTR
9 Meters Biopharma, Inc. Common Stock
NMTR
|
$12.3M |
| 4 |
Amicus Therapeutics
FOLD
|
$11.2M |
| 5 |
Merck
MRK
|
$8.44M |
Top Sells
| 1 |
CEL
Cellcom Israel, Ltd.
CEL
|
$14M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$12.9M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$10.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
$10.1M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
$9.19M |
Sector Composition
| 1 | Healthcare | 86.99% |
| 2 | Technology | 5.23% |
| 3 | Communication Services | 1.51% |
| 4 | Financials | 1.35% |
| 5 | Consumer Discretionary | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MediciNova
MNOV
$64.3M
| $6.45M | 0.98% | +630,838 | New | +$6.45M |
|
27
Nice
NICE
$8.73B
| $6.37M | 0.97% | 67,758 -40,112 | -37% | -$3.77M |
|
|
KDMN
28
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.33M | 0.96% | 1,490,000 +390,000 | +35% | +$1.66M |
|
29
Ascendis Pharma
ASND
$11.8B
| $6.24M | 0.95% | 95,474 -34,000 | -26% | -$2.22M |
|
30
Kura Oncology
KURA
$686M
| $6.19M | 0.94% | +330,000 | New | +$6.19M |
|
31
Microsoft
MSFT
$3.77T
| $6.1M | 0.93% | +66,850 | New | +$6.1M |
|
|
TSRO
32
DELISTED
TESARO, Inc.
TSRO
| $6.07M | 0.92% | 106,175 +11,175 | +12% | +$639K |
|
33
Rocket Pharmaceuticals
RCKT
$354M
| $5.67M | 0.86% | 302,275 +201,834 | +201% | +$3.78M |
|
|
PVLA
34
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.46M | 0.83% | 800,000 | – | – |
|
35
CytomX Therapeutics
CTMX
$336M
| $5.12M | 0.78% | 180,000 +20,000 | +13% | +$569K |
|
36
Flex
FLEX
$20.1B
| $5.03M | 0.76% | +307,839 | New | +$5.03M |
|
37
Delek US
DK
$1.67B
| $4.98M | 0.76% | +122,284 | New | +$4.98M |
|
38
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.97M | 0.75% | 4,792 -975 | -17% | -$1.01M |
|
39
Travere Therapeutics
TVTX
$1.56B
| $4.92M | 0.75% | +220,000 | New | +$4.92M |
|
40
Minerva Neurosciences
NERV
$16.5M
| $4.84M | 0.74% | 775,000 | – | – |
|
41
Visa
V
$683B
| $4.83M | 0.73% | 40,401 -20,000 | -33% | -$2.39M |
|
|
EIGR
42
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.68M | 0.71% | 475,000 -36,469 | -7% | -$359K |
|
|
RETA
43
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.62M | 0.7% | 225,000 | – | – |
|
|
ALNA
44
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $4.52M | 0.69% | 410,199 +85,199 | +26% | +$939K |
|
45
Syndax Pharmaceuticals
SNDX
$1.41B
| $4.25M | 0.64% | 298,472 +50,000 | +20% | +$711K |
|
46
Abeona Therapeutics
ABEO
$350M
| $4.23M | 0.64% | 295,000 +85,000 | +40% | +$1.22M |
|
47
Puma Biotechnology
PBYI
$254M
| $4.08M | 0.62% | 60,000 +25,000 | +71% | +$1.7M |
|
|
SCTL
48
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $4.01M | 0.61% | +364,197 | New | +$4.01M |
|
49
Corvus Pharmaceuticals
CRVS
$428M
| $3.71M | 0.56% | 321,430 +100,000 | +45% | +$1.15M |
|
50
Leap Therapeutics
LPTX
$12M
| $3.55M | 0.54% | +427,086 | New | +$3.55M |
|